<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">        <PMID Version="1">30036253</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>15</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>15</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1536-0229</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>43</Volume>                    <Issue>9</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Clinical nuclear medicine</Title>                <ISOAbbreviation>Clin Nucl Med</ISOAbbreviation>            </Journal>            <ArticleTitle>68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer: A Pilot Prospective Study.</ArticleTitle>            <Pagination>                <MedlinePgn>663-669</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1097/RLU.0000000000002209</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This prospective pilot study investigated the value of Ga-NOTA-RM26, an antagonist targeting gastrin-releasing peptide receptor, in evaluation of breast cancer.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Thirty-five women in suspicion of breast cancer based on mammography or ultrasonography were recruited with informed consent. They underwent PET/CT scans 30 minutes after intravenous injection of Ga-NOTA-RM26 in a dose of 1.85 MBq (0.05 mCi) per kilogram body weight within 1 week before surgery. The Ga-NOTA-RM26 uptake was correlated with the pathological and immunohistochemical findings.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Ga-NOTA-RM26 positivity was found correlated with estrogen receptor (ER) expression (P = 0.006) and menstrual status (P = 0.019). In 34 patients diagnosed with breast cancer, the SUVmax was found significantly higher in the ER-positive breast cancer (4.97 ± 1.89) than in the ER-negative breast cancer (2.78 ± 0.65, P &lt; 0.001). Ga-NOTA-RM26 was also found accumulated in normal breast tissue, with the SUVmax significantly higher in patients at the secretory phase of menstrual cycle (2.27 ± 0.71) than in those at the nonsecretory phase (1.59 ± 0.49, P = 0.017) and postmenopause (1.43 ± 0.44, P = 0.002). If the secretory phase patients were excluded, the sensitivity, specificity, and accuracy for differentiation of breast cancer from breast tissue increased from 85.3%, 86.8%, and 86.1% to 100%, 90.9%, and 95.5%, respectively.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This pilot study indicates that the diagnostic accuracy of Ga-NOTA-RM26 PET/CT in breast cancer may correlate with ER expression and menstrual status of the patient. It may be better to avoid performing this examination during the menstrual secretory phase to reduce physiological uptake in normal breast tissue.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Zang</LastName>                    <ForeName>Jie</ForeName>                    <Initials>J</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Mao</LastName>                    <ForeName>Feng</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, PUMC Hospital, Chinese Academy of Medical Science and PUMC, Beijing, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Hao</ForeName>                    <Initials>H</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Jingjing</ForeName>                    <Initials>J</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Qingxing</ForeName>                    <Initials>Q</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Peng</LastName>                    <ForeName>Li</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, PUMC Hospital, Chinese Academy of Medical Science and PUMC, Beijing, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Fang</ForeName>                    <Initials>F</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Lang</LastName>                    <ForeName>Lixin</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>Xiaoyuan</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhu</LastName>                    <ForeName>Zhaohui</ForeName>                    <Initials>Z</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>Z99 EB999999</GrantID>                    <Acronym>NULL</Acronym>                    <Agency>Intramural NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>ZIA EB000073-07</GrantID>                    <Acronym>NULL</Acronym>                    <Agency>Intramural NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Clin Nucl Med</MedlineTA>            <NlmUniqueID>7611109</NlmUniqueID>            <ISSNLinking>0363-9762</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D018004">Receptors, Bombesin</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Pathol. 1999 Dec;155(6):2067-76</RefSource>                <PMID Version="1">10595936</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2002 Oct;21(4):831-40</RefSource>                <PMID Version="1">12239623</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Clin Oncol. 2014 Dec 10;5(5):982-9</RefSource>                <PMID Version="1">25493234</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2015;16(7):2857-70</RefSource>                <PMID Version="1">25854374</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Nucl Med. 2017 Sep;58(9):1401-1407</RefSource>                <PMID Version="1">28280221</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2011 Nov-Dec;61(6):409-18</RefSource>                <PMID Version="1">21969133</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Nucl Med. 2015 Oct;56(10):1487-93</RefSource>                <PMID Version="1">26251419</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathologe. 1987 May;8(3):138-40</RefSource>                <PMID Version="1">3303008</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2009 Aug 15;15(16):5240-9</RefSource>                <PMID Version="1">19671861</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioconjug Chem. 2013 Jul 17;24(7):1144-53</RefSource>                <PMID Version="1">23763444</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29</RefSource>                <PMID Version="1">22237781</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Endocrinol Metab. 2005 Aug;90(8):4722-9</RefSource>                <PMID Version="1">15941862</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Prostate. 2000 Mar 1;42(4):295-303</RefSource>                <PMID Version="1">10679759</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1995 Jan 15;55(2):280-7</RefSource>                <PMID Version="1">7812958</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Nucl Med Mol Imaging. 2016 May;43(5):964-73</RefSource>                <PMID Version="1">26631238</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Theranostics. 2016 Jun 19;6(10):1641-50</RefSource>                <PMID Version="1">27446498</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16436-41</RefSource>                <PMID Version="1">17056720</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Nucl Med. 2008 Feb;49(2):318-26</RefSource>                <PMID Version="1">18199616</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2014;15(22):10021-5</RefSource>                <PMID Version="1">25520063</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1999 Mar 1;59(5):1152-9</RefSource>                <PMID Version="1">10070977</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2013 Nov 1;31(31):3997-4013</RefSource>                <PMID Version="1">24101045</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Reprod. 2006 Dec;21(12):3103-7</RefSource>                <PMID Version="1">16923748</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acad Radiol. 2007 Aug;14(8):940-4</RefSource>                <PMID Version="1">17659239</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Med. 2006 Sep;119(9 Suppl 1):S31-43</RefSource>                <PMID Version="1">16949387</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Imaging. 2014;13(5):</RefSource>                <PMID Version="1">24825112</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000072078" MajorTopicYN="Y">Positron Emission Tomography Computed Tomography</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019275" MajorTopicYN="Y">Radiopharmaceuticals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018004" MajorTopicYN="N">Receptors, Bombesin</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pmc-release">                <Year>2019</Year>                <Month>09</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>7</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>7</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30036253</ArticleId>            <ArticleId IdType="doi">10.1097/RLU.0000000000002209</ArticleId>            <ArticleId IdType="pmc">PMC6076351</ArticleId>            <ArticleId IdType="mid">NIHMS974578</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>